Cytosorbents (CTSO) EBT (2010 - 2026)
Cytosorbents' (CTSO) quarterly EBT came in at -$11.0 million in Q1 2026, down 646.77% YoY from $2.0 million in Q1 2025, and down 100.84% on a QoQ basis from -$5.5 million in Q4 2025.
Cytosorbents (CTSO) EBT (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of EBT data on file, last reported at -$11.0 million in Q1 2026.
- Quarterly EBT fell 646.77% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$45.3 million (down 645.84% YoY) and the FY2025 annual result came in at -$8.6 million, up 19.54% from the prior year.
- EBT fell to -$11.0 million in Q1 2026, from -$5.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of $2.5 million in Q4 2024 to a low of -$25.2 million in Q2 2025.
- A 5-year average of -$7.1 million and a median of -$6.6 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT soared 135.47% — and 2026, when it sank 646.77%.
- Tracing CTSO's EBT over 5 years: stood at -$1.9 million in 2022, then slumped by 273.84% to -$6.9 million in 2023, then soared by 135.47% to $2.5 million in 2024, then slumped by 323.0% to -$5.5 million in 2025, then plunged by 100.84% to -$11.0 million in 2026.
- The last three EBT figures came in at -$11.0 million (Q1 2026), -$5.5 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 1.52 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 1.56 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 1.06 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 519.80 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 317.50 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 693.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 855.50 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 273.50 Mn |
| 10 | Cytosorbents | 20.86 Mn | 16.45 Mn | 7.05 Mn | -3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.52 Mn |
| Mar 31, 2026 | -11.04 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -3.57 Mn |
| Jun 30, 2025 | -25.21 Mn |
| Mar 31, 2025 | -1.48 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | -6.09 Mn |
| Dec 31, 2023 | -6.95 Mn |
| Sep 30, 2023 | -9.19 Mn |
| Jun 30, 2023 | -6.60 Mn |
| Mar 31, 2023 | -7.32 Mn |
| Dec 31, 2022 | -1.86 Mn |
| Sep 30, 2022 | -12.20 Mn |
| Jun 30, 2022 | -10.88 Mn |
| Mar 31, 2022 | -8.97 Mn |
| Dec 31, 2021 | -10.04 Mn |
| Sep 30, 2021 | -6.41 Mn |